Acute Effects of Heat-Not-Burn, Electronic Vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking ( SUR - VAPES ) 2 Randomized Trial.
Adult
Atherosclerosis
/ epidemiology
Blood Pressure
/ physiology
Cigarette Smoking
/ adverse effects
Cross-Over Studies
Electronic Nicotine Delivery Systems
Female
Follow-Up Studies
Hot Temperature
/ adverse effects
Humans
Incidence
Italy
/ epidemiology
Male
Prognosis
Retrospective Studies
Risk Assessment
/ methods
Vaping
/ adverse effects
flow‐induced dilation
oxidative stress
platelet
platelet aggregation
smoking
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
19 03 2019
19 03 2019
Historique:
entrez:
19
3
2019
pubmed:
19
3
2019
medline:
21
7
2020
Statut:
ppublish
Résumé
Background Little clinical research on new-generation heat-not-burn cigarettes ( HNBC ) in comparison with electronic vaping cigarettes ( EVC ) and traditional tobacco combustion cigarettes ( TC ) has been reported. We aimed to appraise the acute effects of single use of HNBC , EVC, and TC in healthy smokers. Methods and Results This was an independent, cross-over, randomized trial in 20 TC smokers, with allocation to different cycles of HNBC , EVC , and TC . All participants used all types of products, with an intercycle washout of 1 week. End points were oxidative stress, antioxidant reserve, platelet activation, flow-mediated dilation, blood pressure, and satisfaction scores. Single use of any product led to an adverse impact on oxidative stress, antioxidant reserve, platelet function, flow-mediated dilation, and blood pressure. HNBC had less impact than EVC and TC on soluble Nox2-derived peptide (respectively, P=0.004 and 0.001), 8-iso-prostaglandin F2α- III ( P=0.004 and <0.001), and vitamin E ( P=0.018 and 0.044). HNBC and EVC were equally less impactful than TCs on flow-mediated dilation ( P=0.872 for HNBC versus EVC ), H
Identifiants
pubmed: 30879375
doi: 10.1161/JAHA.118.010455
pmc: PMC6475061
doi:
Banques de données
ClinicalTrials.gov
['NCT03301129']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e010455Références
Thromb Haemost. 2015 Mar;113(3):617-24
pubmed: 25392853
J Am Heart Assoc. 2017 Sep 20;6(9):
pubmed: 28931527
Tob Control. 2014 Mar;23(2):133-9
pubmed: 23467656
Atherosclerosis. 2018 Jul;274:29-34
pubmed: 29747088
Am J Prev Med. 2017 Feb;52(2):e33-e66
pubmed: 27914771
J Thromb Haemost. 2012 Jan;10(1):125-32
pubmed: 22066819
Int J Cardiol. 2013 Apr 30;165(1):184-92
pubmed: 22336250
Heart. 2011 Nov;97(21):1776-81
pubmed: 21807659
Eur Heart J. 2007 Mar;28(5):608-12
pubmed: 17298965
Oxid Med Cell Longev. 2014;2014:691015
pubmed: 25180068
Platelets. 2016 Nov;27(7):694-702
pubmed: 27096416
Curr Med Chem. 2007;14(16):1703-12
pubmed: 17627508
Antioxidants (Basel). 2018 Jul 03;7(7):
pubmed: 29970802
Proc Am Thorac Soc. 2008 Dec 1;5(8):811-5
pubmed: 19017734
J Chromatogr A. 2001 Nov 30;936(1-2):83-93
pubmed: 11761008
N Engl J Med. 2014 Jan 2;370(1):60-8
pubmed: 24382066
Chest. 2015 Sep;148(3):580-582
pubmed: 25836723
Chest. 2015 Sep;148(3):582-584
pubmed: 25837266
Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S27-S47
pubmed: 27720919
Chest. 2016 Sep;150(3):606-12
pubmed: 27108682
Psychopharmacology (Berl). 2017 Oct;234(19):2911-2917
pubmed: 28721480
Circulation. 2009 Oct 20;120(16):1616-22
pubmed: 19805647
J Am Coll Cardiol. 2002 Jan 16;39(2):257-65
pubmed: 11788217
Tob Induc Dis. 2018 May 08;16:18
pubmed: 31516418
JAMA Intern Med. 2017 Jul 1;177(7):1050-1052
pubmed: 28531246
Tob Induc Dis. 2014 Dec 09;12(1):23
pubmed: 25620905
Int J Epidemiol. 2015 Jun;44(3):735-43
pubmed: 26174518
J Am Heart Assoc. 2019 Mar 19;8(6):e010455
pubmed: 30879375
Addiction. 2016 Apr;111(4):706-13
pubmed: 26566956
Nicotine Tob Res. 2018 Jan 5;20(2):246-252
pubmed: 28082323
Br J Clin Pharmacol. 2018 Jul;84(7):1566-1574
pubmed: 29577365
N Engl J Med. 2018 Jan 18;378(3):216-219
pubmed: 29342380
Epidemiol Rev. 1996;18(2):188-204
pubmed: 9021312
Tob Control. 2019 Jan;28(1):113-114
pubmed: 29374094
Tob Control. 2019 Jan;28(1):34-41
pubmed: 29535257
JAMA Cardiol. 2017 Mar 1;2(3):278-284
pubmed: 28146259
Tob Control. 2018 Nov;27(Suppl 1):s13-s19
pubmed: 30206183
N Engl J Med. 2016 Dec 29;375(26):2608-2609
pubmed: 28029910
J Pediatr. 2012 Dec;161(6):1004-9
pubmed: 22727869
Am J Cardiol. 2018 Nov 1;122(9):1477-1481
pubmed: 30170691
Nat Rev Immunol. 2004 Mar;4(3):181-9
pubmed: 15039755
Lancet. 2000 Jun 10;355(9220):2013-4
pubmed: 10885350
J Lipid Res. 2013 Sep;54(9):2307-14
pubmed: 23505320
Intern Emerg Med. 2012 Jun;7(3):219-27
pubmed: 21512794
Int J Environ Res Public Health. 2017 Apr 05;14(4):
pubmed: 28379177
N Engl J Med. 2018 Sep 06;379(10):991-2
pubmed: 30188641
BMC Gastroenterol. 2014 Apr 23;14:81
pubmed: 24758604
Trends Cardiovasc Med. 2018 Oct;28(7):429-434
pubmed: 29661712
Addict Behav. 2018 Mar;78:74-79
pubmed: 29127787